Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-26-077506
Filing Date
2026-06-25
Accepted
2026-06-25 06:30:47
Documents
2
Period of Report
2026-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2618527d1_6k.htm 6-K 11510
2 EXHIBIT 99.1 tm2618527d1_ex99-1.htm EX-99.1 30983
  Complete submission text file 0001104659-26-077506.txt   43662
Mailing Address ZERNIKEDREEF 9 LEIDEN Netherlands
Business Address ZERNIKEDREEF 9 LEIDEN Netherlands 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 261117591
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)